Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the target of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 33,600 shares, a drop of 11.1% from the February 29th total of 37,800 shares. Based on an average daily volume of 12,300 shares, […]